Well done to all of you campaigning and protesting against this:
"pupils will no longer be required to wear face coverings in the classroom or communal areas in schools and colleges. This will improve interaction between teachers and students, ensuring the clearest possible communication to support learning."
https://www.gov.uk/government/news/face-coverings-no-longer-required-in-schools-and-colleges-from-17-may
"pupils will no longer be required to wear face coverings in the classroom or communal areas in schools and colleges. This will improve interaction between teachers and students, ensuring the clearest possible communication to support learning."
https://www.gov.uk/government/news/face-coverings-no-longer-required-in-schools-and-colleges-from-17-may
GOV.UK
Face coverings no longer required in schools and colleges from 17 May
Face coverings will no longer have to be worn in classrooms or communal areas by pupils.
"Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19"
https://www.ox.ac.uk/news/2021-04-12-asthma-drug-budesonide-shortens-recovery-time-non-hospitalised-patients-covid-19
https://www.ox.ac.uk/news/2021-04-12-asthma-drug-budesonide-shortens-recovery-time-non-hospitalised-patients-covid-19
University of Oxford
Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19
Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other
Forwarded from Mike Yeadon
Updated and sharpened piece about the official lies & covidcrimes being perpetrated in several countries.
Unless, of course, you’re a “coincidence theorist”.
Cheers,
Mike
Unless, of course, you’re a “coincidence theorist”.
Cheers,
Mike
I don't share much about the origins of SARSCoV2 because personally I have no doubt about it, so I find it less interesting to focus on something I already know. However if any clearer evidence shows up I will share. A lot of us know the names and surnames of the people involved. Fauci, Baric, Daszak, Menachery & Shi Zheng-Li.
Forwarded from Creda von Clausewitz
U.S. Government’s $3.7 Million Grant to Wuhan Lab at Center of Coronavirus Outbreak
Following the 2002-2003 SARS coronavirus outbreak, NIH funded a collaboration by Chinese scientists, US military virologists from the bioweapons lab at Fort Detrick and National Institutes of Health (NIH) scientists from NIAID to prevent future coronavirus outbreaks by studying the evolution of virulent strains from bats in human tissues. Those efforts included “gain of function” research which is “accelerated viral evolution” to create COVID Pandemic superbugs, enhanced bat borne COVID mutants more lethal and more transmissible than wild COVID.
https://childrenshealthdefense.org/news/u-s-governments-3-7-million-grant-to-wuhan-lab-at-center-of-coronavirus-outbreak/
Gain of Function Research
Certain gain-of-function studies with the potential to enhance the pathogenicity or transmissibility of potential pandemic pathogens (PPPs) have raised biosafety and biosecurity concerns, including the potential dual use risks associated with the misuse of the information or products resulting from such research.
On October 16, 2014, the White House Office of Science and Technology Policy announced the launch of the U.S. Government (USG) gain-of-function (GOF) deliberative process to re-evaluate the potential risks and benefits associated with certain GOF experiments. During this process the USG paused the release of federal funding for GOF studies anticipated to enhance the pathogenicity or transmissibility among mammals by respiratory droplets of influenza, MERS, or SARS viruses.
The NSABB served as the official federal advisory body on the GOF issue and was tasked with providing recommendations to the USG on a conceptual approach for evaluating proposed GOF research. The NSABB finalized its recommendations on May 24, 2016. The U.S. Government considered the NSABB’s findings and recommendations during the development of policy on gain-of-function research. In January 2017, the U.S. Government released policy guidance for the review and oversight of research anticipated to create, transfer, or use enhanced PPPs.
https://osp.od.nih.gov/biotechnology/gain-of-function-research/
A Federal Ban on Making Lethal Viruses Is Lifted
Federal officials on Tuesday ended a moratorium imposed three years ago on funding research that alters germs to make them more lethal.
Such work can now proceed, said Dr. Francis S. Collins, the head of the National Institutes of Health, but only if a scientific panel decides that the benefits justify the risks.
Some scientists are eager to pursue these studies because they may show, for example, how a bird flu could mutate to more easily infect humans, or could yield clues to making a better vaccine.
Critics say these researchers risk creating a monster germ that could escape the lab and seed a pandemic.
https://www.nytimes.com/2017/12/19/health/lethal-viruses-nih.html
Lab-Made? SARS-CoV-2 Genealogy Through the Lens of Gain-of-Function Research
Indeed, virologists, including the leader of coronavirus research at the Wuhan Institute of Virology, Shi Zhengli, have done many similar things in the past — both replacing the RBM in one type of virus by an RBM from another, or adding a new furin site that can provide a species-specific coronavirus with an ability to start using the same receptor (e.g. ACE2) in other species. In fact, Shi Zhengli’s group was creating chimeric constructs as far back as 2007 and as recently as 2017, when they created a whole of 8 new chimeric coronaviruses with various RBMs. In 2019 such work was in full swing, as WIV was part of a $3.7 million NIH grant titled Understanding the Risk of Bat Coronavirus Emergence. Under its auspices, Shi Zhengli co-authored a 2019 paper that called for continued research into synthetic viruses and testing them in vitro and in vivo:
Following the 2002-2003 SARS coronavirus outbreak, NIH funded a collaboration by Chinese scientists, US military virologists from the bioweapons lab at Fort Detrick and National Institutes of Health (NIH) scientists from NIAID to prevent future coronavirus outbreaks by studying the evolution of virulent strains from bats in human tissues. Those efforts included “gain of function” research which is “accelerated viral evolution” to create COVID Pandemic superbugs, enhanced bat borne COVID mutants more lethal and more transmissible than wild COVID.
https://childrenshealthdefense.org/news/u-s-governments-3-7-million-grant-to-wuhan-lab-at-center-of-coronavirus-outbreak/
Gain of Function Research
Certain gain-of-function studies with the potential to enhance the pathogenicity or transmissibility of potential pandemic pathogens (PPPs) have raised biosafety and biosecurity concerns, including the potential dual use risks associated with the misuse of the information or products resulting from such research.
On October 16, 2014, the White House Office of Science and Technology Policy announced the launch of the U.S. Government (USG) gain-of-function (GOF) deliberative process to re-evaluate the potential risks and benefits associated with certain GOF experiments. During this process the USG paused the release of federal funding for GOF studies anticipated to enhance the pathogenicity or transmissibility among mammals by respiratory droplets of influenza, MERS, or SARS viruses.
The NSABB served as the official federal advisory body on the GOF issue and was tasked with providing recommendations to the USG on a conceptual approach for evaluating proposed GOF research. The NSABB finalized its recommendations on May 24, 2016. The U.S. Government considered the NSABB’s findings and recommendations during the development of policy on gain-of-function research. In January 2017, the U.S. Government released policy guidance for the review and oversight of research anticipated to create, transfer, or use enhanced PPPs.
https://osp.od.nih.gov/biotechnology/gain-of-function-research/
A Federal Ban on Making Lethal Viruses Is Lifted
Federal officials on Tuesday ended a moratorium imposed three years ago on funding research that alters germs to make them more lethal.
Such work can now proceed, said Dr. Francis S. Collins, the head of the National Institutes of Health, but only if a scientific panel decides that the benefits justify the risks.
Some scientists are eager to pursue these studies because they may show, for example, how a bird flu could mutate to more easily infect humans, or could yield clues to making a better vaccine.
Critics say these researchers risk creating a monster germ that could escape the lab and seed a pandemic.
https://www.nytimes.com/2017/12/19/health/lethal-viruses-nih.html
Lab-Made? SARS-CoV-2 Genealogy Through the Lens of Gain-of-Function Research
Indeed, virologists, including the leader of coronavirus research at the Wuhan Institute of Virology, Shi Zhengli, have done many similar things in the past — both replacing the RBM in one type of virus by an RBM from another, or adding a new furin site that can provide a species-specific coronavirus with an ability to start using the same receptor (e.g. ACE2) in other species. In fact, Shi Zhengli’s group was creating chimeric constructs as far back as 2007 and as recently as 2017, when they created a whole of 8 new chimeric coronaviruses with various RBMs. In 2019 such work was in full swing, as WIV was part of a $3.7 million NIH grant titled Understanding the Risk of Bat Coronavirus Emergence. Under its auspices, Shi Zhengli co-authored a 2019 paper that called for continued research into synthetic viruses and testing them in vitro and in vivo:
PubMed Central (PMC)
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
Ralph Baric, Vineet Menachery and colleagues characterize a SARS-like coronavirus circulating in Chinese horseshoe bats to determine its potential to infect primary human airway epithelial cells, cause disease in mice and respond to available therapeutics.The…